Reverse Mergers and SPACs: Are APOs the New Norm for Biotechs Going Public?
Cybersecurity Best Practices for 2021
Valuation of Your Early Drug Candidate
Getting Ready for a Biopharma Partnering Deal
The Nuts & Bolts of Due Diligence in Biopharma Partnering
What's Hot and What's Not in Oncology Licensing in 2020?
How to Win at the Partnering Game
In this white paper, Linda Pullan provides a review of the rules of the partnering game – whether it’s partnering from preclinical to late clinical development – to provide an understanding of what to expect in moving from introductions to negotiations of a license or acquisition and how to win with a clear strategy.
Paradigm Changing Technologies in Oncology
Pivot to Cash: Bankruptcy & Restructuring in a Distressed Environment
Microbiome: Hope or Hype?
M&A Outlook 2019
This webinar discussion is focused around best practices in due diligence, potential red flags to avoid, and how working with an experienced team of trusted advisors paired with the right tools can help accelerate the discovery process.